Antioxidant supplements relieve insulin resistance but do not improve lipid metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials

References

• Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15.
   PubMed Web of Science ®Google Scholar
• Park HR, Choi Y, Lee HJ, et al. Phenotypic characteristics according to insulin sensitivity in non-obese korean women with polycystic ovary syndrome. Diabetes Res Clin Pract. 2007;77(3): S233–S237.
   PubMedGoogle Scholar
• Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Aponte-Mellado A, Premkumar BJ, et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10:49.
   PubMed Web of Science ®Google Scholar
• Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–62.
   PubMed Web of Science ®Google Scholar
• Al-Gubory KH, Fowler PA, Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol. 2010;42(10):1634–1650.
   PubMed Web of Science ®Google Scholar
• Zhang PY, Xu X, Li XC. Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci. 2014;18(20):3091–3096.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–1761.
   PubMed Web of Science ®Google Scholar
• Henriksen EJ, Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med. 2011;51(5):993–999.
   PubMed Web of Science ®Google Scholar
• Mohammadi M. Oxidative stress and polycystic ovary syndrome: a brief review. Int J Prev Med. 2019;10:86.
   PubMed Web of Science ®Google Scholar
• Göçer H, Akıncıoğlu A, Öztaşkın N, et al. Synthesis, antioxidant, and antiacetylcholinesterase activities of sulfonamide derivatives of dopamine-related compounds. Arch Pharm (Weinheim). 2013;346(11):783–792.
   PubMed Web of Science ®Google Scholar
• Mut-Salud N, Alvarez PJ, Garrido JM, et al. Antioxidant intake and antitumor therapy: toward nutritional recommendations for optimal results. Oxid Med Cell Longev. 2016;2016:6719534.
   PubMed Web of Science ®Google Scholar
• Neha K, Haider MR, Pathak A, et al. Medicinal prospects of antioxidants: a review. Eur J Med Chem. 2019;178:687–704.
   PubMed Web of Science ®Google Scholar
• Gulcin I. Antioxidants and antioxidant methods: an updated overview. Arch Toxicol. 2020;94(3):651–715.
   PubMed Web of Science ®Google Scholar
• Nitta H, Kinoyama M, Watanabe A, et al. Effects of nutritional supplementation with antioxidant vitamins and minerals and fish oil on antioxidant status and psychosocial stress in smokers: an open trial. Clin Exp Med. 2007;7(4):179–183.
   PubMed Web of Science ®Google Scholar
• Hyderali BN, Mala K. Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 2015;191:15–22.
   PubMed Web of Science ®Google Scholar
• Izadi A, Ebrahimi S, Shirazi S, et al. Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104(2):319–327.
   PubMed Web of Science ®Google Scholar
• Afshar Ebrahimi F, Foroozanfard F, Aghadavod E, et al. The effects of magnesium and zinc Co-Supplementation on biomarkers of inflammation and oxidative stress, and gene expression related to inflammation in polycystic ovary syndrome: a randomized controlled clinical trial. Biol Trace Elem Res. 2018;184(2):300–307.
   PubMed Web of Science ®Google Scholar
• Mansour A, Samadi M, Sanginabadi M, et al. Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS. Clin Nutr. 2021;40(6):4106–4112.
   PubMed Web of Science ®Google Scholar
• Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.
   PubMed Web of Science ®Google Scholar
• Higgins J. Cochrane handbook for systematic reviews of interventions version 5.1. 0 (updated on 2011). The Cochrane Collaboration; 2015; p. 164–166. Available from: www.cochrane-Handbook.org.
   Google Scholar
• Banaszewska B, Wrotyńska-Barczyńska J, Spaczynski RZ, et al. Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2016;101(11):4322–4328.
   PubMed Web of Science ®Google Scholar
• Izadi A, Shirazi S, Taghizadeh S, et al. Independent and additive effects of coenzyme Q10 and vitamin E on cardiometabolic outcomes and visceral adiposity in women with polycystic ovary syndrome. Arch Med Res. 2019;50(2):1–10.
   PubMed Web of Science ®Google Scholar
• Rashidi BH, Mohammad Hosseinzadeh F, Alipoor E, et al. Effects of selenium supplementation on asymmetric dimethylarginine and cardiometabolic risk factors in patients with polycystic ovary syndrome. Biol Trace Elem Res. 2020;196(2):430–437.
   PubMed Web of Science ®Google Scholar
• Alizadeh M, Karandish M, Asghari Jafarabadi M, et al. Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Nutr Metab (Lond). 2021;18(1):57.
   PubMed Web of Science ®Google Scholar
• Amini M, Bahmani F, Foroozanfard F, et al. The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. J Psychosom Obstet Gynaecol. 2018:1–9.
   PubMed Web of Science ®Google Scholar
• Ebrahimi FA, Samimi M, Foroozanfard F, et al. The effects of omega-3 fatty acids and vitamin E Co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2017;125(6):353–359.
   PubMed Web of Science ®Google Scholar
• Foroozanfard F, Jamilian M, Jafari Z, et al. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2015;123(4):215–220.
   PubMed Web of Science ®Google Scholar
• Jamilian M, Foroozanfard F, Kavossian E, et al. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Nutr ESPEN. 2020;36:128–133.
   PubMed Web of Science ®Google Scholar
• Jamilian M, Razavi M, Fakhrie Kashan Z, et al. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2015;82(6):885–891.
   PubMed Web of Science ®Google Scholar
• Khorshidi M, Moini A, Alipoor E, et al. The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome. Phytother Res. 2018;32(11):2282–2289.
   PubMed Web of Science ®Google Scholar
• Mirmasoumi G, Fazilati M, Foroozanfard F, et al. The effects of flaxseed oil omega-3 fatty acids supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2018;126(4):222–228.
   PubMed Web of Science ®Google Scholar
• Rafraf M, Mohammadi E, Asghari-Jafarabadi M, et al. Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome. J Am Coll Nutr. 2012;31(5):361–368.
   PubMed Web of Science ®Google Scholar
• Rahmani E, Samimi M, Ebrahimi FA, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol Cell Endocrinol. 2017;439:247–255.
   PubMed Web of Science ®Google Scholar
• Rezvan N, Moini A, Janani L, et al. Effects of quercetin on adiponectin-mediated insulin sensitivity in polycystic ovary syndrome: a randomized placebo-controlled double-blind clinical trial. Horm Metab Res. 2017;49(2):115–121.
   PubMed Web of Science ®Google Scholar
• Samimi M, Zarezade Mehrizi M, Foroozanfard F, et al. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2017;86(4):560–566.
   PubMed Web of Science ®Google Scholar
• Shabani A, Foroozanfard F, Kavossian E, et al. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. J Affect Disord. 2019;250:51–56.
   PubMed Web of Science ®Google Scholar
• Sohaei S, Amani R, Tarrahi MJ, et al. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial. Complement Ther Med. 2019;47:102201.
   PubMed Web of Science ®Google Scholar
• Mancini A, Martorana GE, Magini M, et al. Oxidative stress and metabolic syndrome: effects of a natural antioxidants enriched diet on insulin resistance. Clin Nutr ESPEN. 2015;10(2):e52–e60.
   PubMedGoogle Scholar
• Mancini A, Bruno C, Vergani E, et al. Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights. Int J Mol Sci. 2021;22(4):1667.
   PubMed Web of Science ®Google Scholar
• Chien YJ, Chang CY, Wu MY, et al. Effects of curcumin on glycemic control and lipid profile in polycystic ovary syndrome: systematic review with Meta-Analysis and trial sequential analysis. Nutrients. 2021;13(2):684.
   PubMed Web of Science ®Google Scholar
• Yang K, Zeng L, Bao T, et al. Effectiveness of omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2018;16(1):27.
   PubMedGoogle Scholar
• Gharaei R, Mahdavinezhad F, Samadian E, et al. Antioxidant supplementations ameliorate PCOS complications: a review of RCTs and insights into the underlying mechanisms. J Assist Reprod Genet. 2021;38(11):2817–2831.
   PubMed Web of Science ®Google Scholar
• Stanczyk FZ. Diagnosis of hyperandrogenism: biochemical criteria. Best Pract Res Clin Endocrinol Metab. 2006;20(2):177–191.
   PubMed Web of Science ®Google Scholar
• Di Stasi V, Maseroli E, Rastrelli G, et al. SHBG as a marker of NAFLD and metabolic impairments in women referred for oligomenorrhea and/or hirsutism and in women with sexual dysfunction. Front Endocrinol (Lausanne). 2021;12:641446.
   PubMed Web of Science ®Google Scholar
• Zhu JL, Chen Z, Feng WJ, et al. Sex hormone-binding globulin and polycystic ovary syndrome. Clin Chim Acta. 2019;499:142–148.
   PubMed Web of Science ®Google Scholar
• Karakas SE. New biomarkers for diagnosis and management of polycystic ovary syndrome. Clin Chim Acta. 2017;471:248–253.
   PubMed Web of Science ®Google Scholar
• Zeb A. Concept, mechanism, and applications of phenolic antioxidants in foods. J Food Biochem. 2020;44(9):e13394.
   PubMed Web of Science ®Google Scholar
• Tefagh G, Payab M, Qorbani M, et al. Effect of vitamin E supplementation on cardiometabolic risk factors, inflammatory and oxidative markers and hormonal functions in PCOS (polycystic ovary syndrome): a systematic review and meta-analysis. Sci Rep. 2022;12(1):5770.
   PubMed Web of Science ®Google Scholar
• Abdelazeem B, Abbas KS, Shehata J, et al. The effects of curcumin as dietary supplement for patients with polycystic ovary syndrome: an updated systematic review and meta-analysis of randomized clinical trials. Phytother Res. 2022;36(1):22–32.
   PubMed Web of Science ®Google Scholar
• Pourteymour Fard Tabrizi F, Hajizadeh-Sharafabad F, Vaezi M, et al. Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review. J Ovarian Res. 2020;13(1):11.
   PubMed Web of Science ®Google Scholar
• He L, He T, Farrar S, et al. Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species. Cell Physiol Biochem. 2017;44(2):532–553.
   PubMedGoogle Scholar
• Hu KL, Ye X, Wang S, et al. Melatonin application in assisted reproductive technology: a systematic review and Meta-Analysis of randomized trials. Front Endocrinol (Lausanne). 2020;11:160.
   PubMed Web of Science ®Google Scholar
• Nasiadek M, Stragierowicz J, Klimczak M, et al. The role of zinc in selected female reproductive system disorders. Nutrients. 2020;12(8):2464.
   PubMed Web of Science ®Google Scholar
• Kapoor B, Kapoor D, Gautam S, et al. Dietary polyunsaturated fatty acids (PUFAs): uses and potential health benefits. Curr Nutr Rep. 2021;10(3):232–242.
   PubMedGoogle Scholar
• Xia Y, Wang Y, Cui M, et al. Efficacy of omega-3 fatty acid supplementation on cardiovascular risk factors in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(6):6425–6437.
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Esteban-Zubero E, et al. Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules. 2015;20(10):18886–18906.
   PubMed Web of Science ®Google Scholar
• Cardinali DP, Vigo DE. Melatonin, mitochondria, and the metabolic syndrome. Cell Mol Life Sci. 2017;74(21):3941–3954.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu Z. Effects of melatonin supplementation on insulin levels and insulin resistance: a systematic review and meta-analysis of randomized controlled trials. Horm Metab Res. 2021;53(9):616–624.
   PubMedGoogle Scholar
• Miele C, Amin MM, Asaad GF, et al. Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats. PloS One. 2014;9(2):e89169.
   PubMed Web of Science ®Google Scholar
• Papucci L, Schiavone N, Witort E, et al. Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J Biol Chem. 2003;278(30):28220–28228.
   PubMed Web of Science ®Google Scholar
• McCarty MF. Can correction of Sub-optimal coenzyme Q status improve beta-cell function in type II diabetics? Med Hypotheses. 1999;52(5):397–400.
   PubMed Web of Science ®Google Scholar
• Rahmani E, Jamilian M, Samimi M, et al. The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(3):217–222.
   PubMed Web of Science ®Google Scholar